tiprankstipranks
Prelude Therapeutics Unveils Educational SMARCA Series
PremiumCompany AnnouncementsPrelude Therapeutics Unveils Educational SMARCA Series
1M ago
Prelude Therapeutics to Participate in Upcoming Healthcare Conferences
PremiumPress Releases
Prelude Therapeutics to Participate in Upcoming Healthcare Conferences
1M ago
Prelude Therapeutics files $400M mixed securities shelf
PremiumThe Fly
Prelude Therapeutics files $400M mixed securities shelf
2M ago
Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
PremiumPress ReleasesPrelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
2M ago
Prelude Therapeutics participates in a conference call with JMP Securities
PremiumThe Fly
Prelude Therapeutics participates in a conference call with JMP Securities
3M ago
Prelude Therapeutics participates in a conference call with JMP Securities
PremiumThe Fly
Prelude Therapeutics participates in a conference call with JMP Securities
3M ago
Prelude Therapeutics to Participate in Barclays Global Healthcare Conference
PremiumPress ReleasesPrelude Therapeutics to Participate in Barclays Global Healthcare Conference
5M ago
Prelude Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Prelude Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
5M ago
New Accounting & Financial Operations Risk for Prelude Therapeutics, Inc. – What’s the Latest?
PremiumMarket News
New Accounting & Financial Operations Risk for Prelude Therapeutics, Inc. – What’s the Latest?
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100